Ocular Therapeutix, Inc. ( OCUL) - Key Metrics
OCUL Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.06 | -$0.35 | -$0.30 | -$0.31 |
| 2026Q1 | $0.05 | -$0.40 | -$0.29 | -$0.32 |
| 2025Q4 | $0.06 | -$0.29 | -$0.24 | -$0.26 |
| 2025Q3 | $0.08 | -$0.38 | -$0.28 | -$0.31 |
| 2025Q2 | $0.08 | -$0.39 | -$0.32 | -$0.33 |
OCUL Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -7.01 |
| 2026Q1 | 0% | -5.29 |
| 2025Q4 | 0% | -10.47 |
| 2025Q3 | 0% | -7.69 |
| 2025Q2 | 0% | -5.95 |
OCUL
Price: $10.04
52 week price:
Payout Ratio Range:
Earnings Per Share: -1.47 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 567800
Ebitda: -14.6 millionMarket Capitalization: 2.2 billion